Cory Lunger has battled ALL since 2008. Throughout the course of his disease he was faced with limited treatment options. There are few clinical trials available to adults diagnosed with this disease; even fewer for those who relapse after initial treatment.
In creating this endowment Cory hopes to change the course of those affected by ALL.
We need more research.
We need more clinical trials.
We need a world without ALL.
In 2012 approximately 2023 adults were diagnosed with ALL, with 1144 dying from the disease. Current chemotherapy regimes have an 80% success rate in placing the disease in remission, however outcomes after the disease returns remain poor. A second remission occurs less than 50% of the time and long term disease survival is rare.
Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
As one of the nation’s leading comprehensive cancer centers, our groundbreaking discoveries are changing the way the world diagnoses, treats and prevents cancer. We are the Midwest’s first freestanding cancer hospital, and our cancer experts offer leading-edge cancer treatments tailored to individual patients because no two cancers, or two patients, are alike. Investing in the cancer experts at Ohio State fuels the groundbreaking discoveries that will lead to our vision of a cancer-free world, Through your generous contributions, you impact cancer research, patient care and community education, extending and improving the lives of those who are affected by cancer.